147 related articles for article (PubMed ID: 35738959)
1. Physical Activity in Young BRCA Carriers and Reduced Risk of Breast Cancer.
Bucy AM; Valencia CI; Howe CL; Larkin TJ; Conard KD; Anderlik EW; Valdivi SI; Bea JW
Am J Prev Med; 2022 Nov; 63(5):837-845. PubMed ID: 35738959
[TBL] [Abstract][Full Text] [Related]
2. Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.
Eleje GU; Eke AC; Ezebialu IU; Ikechebelu JI; Ugwu EO; Okonkwo OO
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012464. PubMed ID: 30141832
[TBL] [Abstract][Full Text] [Related]
3. Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.
Franceschini G; Di Leone A; Terribile D; Sanchez MA; Masetti R
Ann Ital Chir; 2019; 90():1-2. PubMed ID: 30872561
[TBL] [Abstract][Full Text] [Related]
4. Physical activity during adolescence and young adulthood and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
Lammert J; Lubinski J; Gronwald J; Huzarski T; Armel S; Eisen A; Meschino WS; Lynch HT; Snyder C; Eng C; Olopade OI; Ginsburg O; Foulkes WD; Elser C; Cohen SA; Kiechle M; Narod SA; Kotsopoulos J
Breast Cancer Res Treat; 2018 Jun; 169(3):561-571. PubMed ID: 29404807
[TBL] [Abstract][Full Text] [Related]
5. Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
Jernström H; Lubinski J; Lynch HT; Ghadirian P; Neuhausen S; Isaacs C; Weber BL; Horsman D; Rosen B; Foulkes WD; Friedman E; Gershoni-Baruch R; Ainsworth P; Daly M; Garber J; Olsson H; Sun P; Narod SA
J Natl Cancer Inst; 2004 Jul; 96(14):1094-8. PubMed ID: 15265971
[TBL] [Abstract][Full Text] [Related]
6. Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study.
Kauff ND; Domchek SM; Friebel TM; Robson ME; Lee J; Garber JE; Isaacs C; Evans DG; Lynch H; Eeles RA; Neuhausen SL; Daly MB; Matloff E; Blum JL; Sabbatini P; Barakat RR; Hudis C; Norton L; Offit K; Rebbeck TR
J Clin Oncol; 2008 Mar; 26(8):1331-7. PubMed ID: 18268356
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of decision aids for female BRCA1 and BRCA2 mutation carriers: a systematic review.
Krassuski L; Vennedey V; Stock S; Kautz-Freimuth S
BMC Med Inform Decis Mak; 2019 Aug; 19(1):154. PubMed ID: 31370837
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of Prophylactic Surgeries in BRCA1 or BRCA2 Mutation Carriers: A Meta-analysis and Systematic Review.
Li X; You R; Wang X; Liu C; Xu Z; Zhou J; Yu B; Xu T; Cai H; Zou Q
Clin Cancer Res; 2016 Aug; 22(15):3971-81. PubMed ID: 26979395
[TBL] [Abstract][Full Text] [Related]
9. Age at first full-term birth and breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Kotsopoulos J; Gronwald J; Lynch HT; Eisen A; Neuhausen SL; Tung N; Ainsworth P; Weitzel JN; Pal T; Foulkes WD; Eng C; Singer CF; Senter L; Sun P; Lubinski J; Narod SA;
Breast Cancer Res Treat; 2018 Sep; 171(2):421-426. PubMed ID: 29774471
[TBL] [Abstract][Full Text] [Related]
10. Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
Narod SA; Dubé MP; Klijn J; Lubinski J; Lynch HT; Ghadirian P; Provencher D; Heimdal K; Moller P; Robson M; Offit K; Isaacs C; Weber B; Friedman E; Gershoni-Baruch R; Rennert G; Pasini B; Wagner T; Daly M; Garber JE; Neuhausen SL; Ainsworth P; Olsson H; Evans G; Osborne M; Couch F; Foulkes WD; Warner E; Kim-Sing C; Olopade O; Tung N; Saal HM; Weitzel J; Merajver S; Gauthier-Villars M; Jernstrom H; Sun P; Brunet JS
J Natl Cancer Inst; 2002 Dec; 94(23):1773-9. PubMed ID: 12464649
[TBL] [Abstract][Full Text] [Related]
11. BRCA1/BRCA2 mutations in Japanese women with ductal carcinoma in situ.
Liu Y; Ide Y; Inuzuka M; Tazawa S; Kanada Y; Matsunaga Y; Kuwayama T; Sawada T; Akashi-Tanaka S; Nakamura S
Mol Genet Genomic Med; 2019 Mar; 7(3):e493. PubMed ID: 30652428
[TBL] [Abstract][Full Text] [Related]
12. Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers.
Milne RL; Osorio A; Ramón y Cajal T; Baiget M; Lasa A; Diaz-Rubio E; de la Hoya M; Caldés T; Teulé A; Lázaro C; Blanco I; Balmaña J; Sánchez-Ollé G; Vega A; Blanco A; Chirivella I; Esteban Cardeñosa E; Durán M; Velasco E; Martínez de Dueñas E; Tejada MI; Miramar MD; Calvo MT; Guillén-Ponce C; Salazar R; San Román C; Urioste M; Benítez J
Breast Cancer Res Treat; 2010 Jan; 119(1):221-32. PubMed ID: 19370414
[TBL] [Abstract][Full Text] [Related]
13. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Nelson HD; Pappas M; Cantor A; Haney E; Holmes R
JAMA; 2019 Aug; 322(7):666-685. PubMed ID: 31429902
[TBL] [Abstract][Full Text] [Related]
14. The incidence of cardiomyopathy in BRCA1 and BRCA2 mutation carriers after anthracycline-based adjuvant chemotherapy.
Pearson EJ; Nair A; Daoud Y; Blum JL
Breast Cancer Res Treat; 2017 Feb; 162(1):59-67. PubMed ID: 28066861
[TBL] [Abstract][Full Text] [Related]
15. Second primary breast cancer in BRCA1 and BRCA2 mutation carriers: 10-year cumulative incidence in the Breast Cancer Family Registry.
Menes TS; Terry MB; Goldgar D; Andrulis IL; Knight JA; John EM; Liao Y; Southey M; Miron A; Chung W; Buys SS
Breast Cancer Res Treat; 2015 Jun; 151(3):653-60. PubMed ID: 25975955
[TBL] [Abstract][Full Text] [Related]
16. Physical activity and the risk of breast cancer in BRCA1/2 mutation carriers.
Pijpe A; Manders P; Brohet RM; Collée JM; Verhoef S; Vasen HF; Hoogerbrugge N; van Asperen CJ; Dommering C; Ausems MG; Aalfs CM; Gomez-Garcia EB; ; Van't Veer LJ; van Leeuwen FE; Rookus MA
Breast Cancer Res Treat; 2010 Feb; 120(1):235-44. PubMed ID: 19680614
[TBL] [Abstract][Full Text] [Related]
17. Endometrial Cancer in Germline BRCA Mutation Carriers: A Systematic Review and Meta-analysis.
Matanes E; Volodarsky-Perel A; Eisenberg N; Rottenstreich M; Yasmeen A; Mitric C; Lau S; Salvador S; Gotlieb WH; Kogan L
J Minim Invasive Gynecol; 2021 May; 28(5):947-956. PubMed ID: 33249269
[TBL] [Abstract][Full Text] [Related]
18. Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS).
Andrieu N; Goldgar DE; Easton DF; Rookus M; Brohet R; Antoniou AC; Peock S; Evans G; Eccles D; Douglas F; Noguès C; Gauthier-Villars M; Chompret A; Van Leeuwen FE; Kluijt I; Benitez J; Arver B; Olah E; Chang-Claude J; ; ; ;
J Natl Cancer Inst; 2006 Apr; 98(8):535-44. PubMed ID: 16622123
[TBL] [Abstract][Full Text] [Related]
19. Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
Kotsopoulos J; Lubinski J; Lynch HT; Neuhausen SL; Ghadirian P; Isaacs C; Weber B; Kim-Sing C; Foulkes WD; Gershoni-Baruch R; Ainsworth P; Friedman E; Daly M; Garber JE; Karlan B; Olopade OI; Tung N; Saal HM; Eisen A; Osborne M; Olsson H; Gilchrist D; Sun P; Narod SA
Cancer Causes Control; 2005 Aug; 16(6):667-74. PubMed ID: 16049805
[TBL] [Abstract][Full Text] [Related]
20. Variation of breast cancer risk among BRCA1/2 carriers.
Begg CB; Haile RW; Borg A; Malone KE; Concannon P; Thomas DC; Langholz B; Bernstein L; Olsen JH; Lynch CF; Anton-Culver H; Capanu M; Liang X; Hummer AJ; Sima C; Bernstein JL
JAMA; 2008 Jan; 299(2):194-201. PubMed ID: 18182601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
